Loading...

News List

Nature Biotechnology | 抗体药物偶联物(ADCs):开创精准癌症治疗新纪元

2024-03-15


近期的研究表明,通过改进连接技术和开发新型药物载体,ADCs能够更有效地杀死癌细胞,同时减少对健康细胞的损害。抗体药物偶联物(Antibody-Drug Conjugates,简称ADCs),作为一种新兴的抗癌治疗方法,近年来在生物医药领域引起了广泛关注。ADCs通过将强效的抗癌药物与特异性抗体连接在一起,能够将药物直接输送至癌细胞,从而最大限度地提高疗效,同时减少对正常细胞的损害。

Pre: The oral version of Semaglutide was approved for domestic market, and clinical results showed that it can effectively reduce blood sugar and lose weight

Next: Nature Biotechnology | Antibody Drug Conjugators (ADCs) : ushering in a new era of precision cancer therapy